CTSS and neoplasm: After demonstrating the protein degradation efficacy and cytotoxicity of PSRNs in vitro, we proceeded to examine the impact of the pH/cathepsin sequential responsive delivery strategy on in vivo degradation and anti-tumor efficacy.